Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Autor: Kaufman, Peter A., Wildiers, Hans, Freyer, Gilles, Kemeny, Margaret, Gonçalves, Anthony, Jerusalem, Guy, Stopeck, Alison, Vrindavanam, Nandagopal, Dalenc, Florence, Nanayakkara, Nuwan, Wu, Benjamin, Pickett, Cheryl A.
Zdroj: In Clinical Breast Cancer February 2019 19(1):47-57
Databáze: ScienceDirect